[1] |
Shahi F, Khosravi AD, Tabandeh MR, et al. Investigation of the Rv3065, Rv2942, Rv1258c, Rv1410c, and Rv2459 efflux pump genes expression among multidrug-resistant Mycobacterium tuberculosis clinical isolates. Heliyon, 2021, 7(7): e07566. doi:10.1016/j.heliyon.2021.e07566.
doi: 10.1016/j.heliyon.2021.e07566
|
[2] |
Du D, Wang-Kan X, Neuberger A, et al. Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol, 2018, 16(9): 523-539. doi:10.1038/s41579-018-0048-6.
doi: 10.1038/s41579-018-0048-6
pmid: 30002505
|
[3] |
Cohen SB, Gern BH, Delahaye JL, et al. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. Cell Host Microbe, 2018, 24(3): 439-446. doi:10.1016/j.chom.2018.08.001.
doi: S1931-3128(18)30410-4
pmid: 30146391
|
[4] |
Simmons JD, Stein CM, Seshadri C, et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol, 2018, 18(9): 575-589. doi:10.1038/s41577-018-0025-3.
doi: 10.1038/s41577-018-0025-3
pmid: 29895826
|
[5] |
Ramon-Garcia S, Martin C, De Rossi E, et al. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J Antimicrob Chemother, 2007, 59(3): 544-547. doi:10.1093/jac/dkl510.
doi: 10.1093/jac/dkl510
URL
|
[6] |
Sen T, Neog K, Sarma S, et al. Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria. Bioorg Med Chem, 2018, 26(17): 4942-4951. doi:10.1016/j.bmc.2018.08.034.
doi: 10.1016/j.bmc.2018.08.034
|
[7] |
Rai D, Mehraa S. The Mycobacterial Efflux Pump EfpA Can Induce High Drug Tolerance to Many Antituberculosis Drugs, Including Moxifloxacin, in Mycobacterium smegmatis. Antimicrob Agents Chemother, 2021, 65(11): e0026221. doi:10.1128/AAC.00262-21.
doi: 10.1128/AAC.00262-21
|
[8] |
Stutz MD, Allison CC, Ojaimi S, et al. Macrophage and neutrophil death programs differentially confer resistance to tuberculosis. Immunity, 2021, 54(8): 1758-1771.e7. doi:10.1016/j.immuni.2021.06.009.
doi: 10.1016/j.immuni.2021.06.009
pmid: 34256013
|
[9] |
Master SS, Rampini SK, Davis AS, et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe, 2008, 3(4): 224-232. doi:10.1016/j.chom.2008.03.003.
doi: 10.1016/j.chom.2008.03.003
URL
|
[10] |
Zhou Z, He H, Wang K, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science, 2020, 368(6494):eaa27548. doi:10.1126/science.aaz7548.
doi: 10.1126/science.aaz7548
|
[11] |
Chim N, Torres R, Liu Y, et al. The Structure and Interactions of Periplasmic Domains of Crucial MmpL Membrane Proteins from Mycobacterium tuberculosis. Chem Biol, 2015, 22(8): 1098-1107. doi:10.1016/j.chembiol.2015.07.013.
doi: 10.1016/j.chembiol.2015.07.013
URL
|
[12] |
Radchenko M, Symersky J, Nie R, et al. Structural basis for the blockade of MATE multidrug efflux pumps. Nat Commun, 2015, 6: 7995. doi:10.1038/ncomms8995.
doi: 10.1038/ncomms8995
pmid: 26246409
|
[13] |
Bandyopadhyay U, Chadha A, Gupta P, et al. Suppression of Toll-like receptor 2-mediated proinflammatory responses by Mycobacterium tuberculosis protein Rv3529c. J Leukoc Biol, 2017, 102(5): 1249-1259. doi:10.1189/jlb.4A0217-042R.
doi: 10.1189/jlb.4A0217-042R
URL
|
[14] |
Piddock LJ. Multidrug-resistance efflux pumps—not just for resistance. Nat Rev Microbiol, 2006, 4(8): 629-636. doi:10.1038/nrmicro1464.
doi: 10.1038/nrmicro1464
pmid: 16845433
|
[15] |
Li G, Zhang J, Guo Q, et al. Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates. J Antibiot (Tokyo), 2015, 68(7): 431-435. doi:10.1038/ja.2015.9.
doi: 10.1038/ja.2015.9
|
[16] |
Howard NC, Marin ND, Ahmed M, et al. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat Microbiol, 2018, 3(10): 1099-1108. doi:10.1038/s41564-018-0245-0.
doi: 10.1038/s41564-018-0245-0
|
[17] |
Lovey A, Verma S, Kaipilyawar V, et al. Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains. Nat Commun, 2022, 13(1): 884. doi:10.1038/s41467-022-28506-2.
doi: 10.1038/s41467-022-28506-2
|
[18] |
Khan N, Mendonca L, Dhariwal A, et al. Intestinal dysbiosis compromises alveolar macrophage immunity to Mycobacterium tuberculosis. Mucosal Immunol, 2019, 12(3): 772-783. doi:10.1038/s41385-019-0147-3.
doi: 10.1038/s41385-019-0147-3
URL
|
[19] |
Akter S, Chauhan KS, Dunlap MD, et al. Mycobacterium tuberculosis infection drives a type Ⅰ IFN signature in lung lymphocytes. Cell Rep, 2022, 39(12): 110983. doi:10.1016/j.celrep.2022.110983.
doi: 10.1016/j.celrep.2022.110983
|
[20] |
Gutierrez MG, Mishra BB, Jordao L, et al. NF-kappa B activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages. J Immunol, 2008, 181(4): 2651-2663. doi:10.4049/jimmunol.181.4.2651.
doi: 10.4049/jimmunol.181.4.2651
pmid: 18684956
|
[21] |
Mele F, Basso C, Leoni C, et al. ERK phosphorylation and miR-181a expression modulate activation of human memory TH17 cells. Nat Commun, 2015, 6: 6431. doi:10.1038/ncomms7431.
doi: 10.1038/ncomms7431
pmid: 25775432
|
[22] |
Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe, 2008, 3(6): 399-407. doi:10.1016/j.chom.2008.05.006.
doi: 10.1016/j.chom.2008.05.006
pmid: 18541216
|
[23] |
Lucas RM, Liu L, Curson JEB, et al. SCIMP is a spatiotemporal transmembrane scaffold for Erk1/ 2 to direct pro-inflammatory signaling in TLR-activated macrophages. Cell Rep, 2021, 36(10): 109662. doi:10.1016/j.celrep.2021.109662.
doi: 10.1016/j.celrep.2021.109662
|
[24] |
Prieto P, Cuenca J, Traves P, et al. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways. Cell Death Differ, 2010, 17(7): 1179-1188. doi:10.1038/cdd.2009.220.
doi: 10.1038/cdd.2009.220
pmid: 20094061
|
[25] |
Lorenz K, Schmitt JP, Schmittecker EM, et al. A new type of ERK1/ 2 autophosphorylation causes cardiac hypertrophy. Nat Med, 2009, 15(1): 75-83. doi:10.1038/nm.1893.
doi: 10.1038/nm.1893
|
[26] |
Qiang L, Zhang Y, Liu CH. Mycobacterium tuberculosis effector proteins: functional multiplicity and regulatory diversity. Cell Mol Immunol, 2021, 18(5): 1343-1344. doi:10.1038/s41423-021-00676-x.
doi: 10.1038/s41423-021-00676-x
|